A CAR-T trial is one of several efforts that suggest there’s hope of treating the “worst imaginable childhood brain tumor,” ...

Nine of 11 patients in new brain cancer trial saw their tumors shrink by at least half. One really beat the odds.

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in ...

In another triumph for AI in healthcare, researchers have developed a model that can spot bits of brain tumors that surgeons ...

In a trial with 11 patients with midline diffuse glioma, 9 showed benefits from the cellular therapy. In one case, the tumor ...

A novel vaccine can mobilize the immune system to precisely target and attack cancerous brain tumors, specifically gliomas, ...

Glioma, tumors that form in the glial cells of the brain and spinal cord, can present as benign (non-cancerous) or malignant ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Researchers have developed an AI-powered model that—in 10 seconds—can determine during surgery if any part of a cancerous ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...